Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
370M
-
Number of holders
-
135
-
Total 13F shares, excl. options
-
57.4M
-
Shares change
-
-4.07M
-
Total reported value, excl. options
-
$66M
-
Value change
-
-$3.64M
-
Put/Call ratio
-
0.4
-
Number of buys
-
42
-
Number of sells
-
-74
-
Price
-
$1.15
Significant Holders of PRECIGEN, INC. - Common Stock (PGEN) as of Q2 2023
170 filings reported holding PGEN - PRECIGEN, INC. - Common Stock as of Q2 2023.
PRECIGEN, INC. - Common Stock (PGEN) has 135 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 57.4M shares
of 370M outstanding shares and own 15.5% of the company stock.
Largest 10 shareholders include Patient Capital Management, LLC (11.2M shares), BlackRock Inc. (10.4M shares), VANGUARD GROUP INC (6.82M shares), IRIDIAN ASSET MANAGEMENT LLC/CT (3.33M shares), GEODE CAPITAL MANAGEMENT, LLC (2.88M shares), STATE STREET CORP (2.59M shares), RENAISSANCE TECHNOLOGIES LLC (1.48M shares), JACOBS LEVY EQUITY MANAGEMENT, INC (1.35M shares), JPMORGAN CHASE & CO (1.2M shares), and NORTHERN TRUST CORP (1.11M shares).
This table shows the top 135 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.